Issue Briefs

August 2016 – Biosimilars

Volume 2 Issue 3 – 2016
Ivonne Fuller Cameron*, Lauren Healy and Willis Chang
*Corresponding author: Ivonne Fuller Cameron, President & CEO, Hepatitis Foundation International, World Headquarters, 8121 Georgia Avenue, Suite 350, Silver Spring, MD 20910, USA, Tel: 301.565.9410  Email: ifcameron@hepatitisfoundation.org 


May 2016Hard to Reach, Hard to Treat (HRHT)™ 

Viral hepatitis is a major chronic viral infection that affects millions of people throughout the world.

 

 



Feb 2016 – Viral Hepatitis and Stigma

Viral hepatitis impacts millions of people worldwide and is a major chronic viral infection. The hepatitis C virus (HCV) affects approximately 170-200 million people1, while chronic hepatitis B affects approximately 350 million people.